Alx Oncology Holdings (ALXO) Accounts Payables (2019 - 2026)

Alx Oncology Holdings' Accounts Payables history runs 8 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Accounts Payables fell 2.11% year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $3.9 million (down 2.11% YoY), while the FY2025 annual figure was $4.9 million, up 9.27% from the prior year.
• Accounts Payables came in at $3.9 million for Q1 2026 at Alx Oncology Holdings, down from $4.9 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $13.0 million in Q3 2023 to a low of $3.9 million in Q1 2026.
• A 5-year average of $6.7 million and a median of $6.2 million in 2024 frame the typical range for Accounts Payables.
• On a YoY basis, Accounts Payables climbed as much as 121.11% in 2023 and fell as far as 52.59% in 2023.
• Alx Oncology Holdings' Accounts Payables stood at $8.1 million in 2022, then gained by 6.42% to $8.6 million in 2023, then tumbled by 47.65% to $4.5 million in 2024, then grew by 9.27% to $4.9 million in 2025, then decreased by 21.57% to $3.9 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $3.9 million, $4.9 million, and $6.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison